Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
| EXELIXIS | 9 | 8 | -1,65 % | ||
| BIONTECH | 6 | 13 | +1,03 % | ||
| 10X GENOMICS | 4 | 10 | +1,13 % | ||
| ALLOGENE THERAPEUTICS | 4 | 6 | 0,00 % | ||
| SCPHARMACEUTICALS | 4 | - | +10,95 % | ||
| SCHOLAR ROCK | 4 | - | -2,19 % | ||
| CENTESSA PHARMACEUTICALS | 4 | - | 0,00 % | ||
| MODERNA | 3 | 16 | +0,33 % | ||
| HALOZYME THERAPEUTICS | 3 | 6 | -0,21 % | ||
| ALUMIS | 3 | 2 | 0,00 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 08:15 | Dividendenbekanntmachungen (15.05.2025) | 347 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) 1ST SOURCE CORPORATION US3369011032 0,38 USD EUR APPLE INC US0378331005 0,26 USD EUR ATHELNEY TRUST PLC GB0000609296 0,076... ► Artikel lesen | |
| 08:13 | Novavax Aktie: Sondermeldung sorgt für starke Verunsicherung. Das ist der Grund und so müssen Anleger heute handeln! | Felix Haupt | |||
| 06:24 | ScPharmaceuticals targets CKD launch and rising Medicare fill rates to accelerate FUROSCIX growth trajectory | 2 | Seeking Alpha | ||
| 05:29 | Mesoblast Secures FDA Orphan-Drug Approval For Ryoncil | 3 | RTTNews | ||
| 05:00 | Mesoblast Limited: FDA Provides Seven Years of Orphan-Drug Exclusive Approval for Ryoncil | 2 | GlobeNewswire (USA) | ||
| 04:10 | Thursday's HotCopper trends: Mesoblast's FDA tick, Anson's green light | May 15, 2025 | 1 | The Market Herald Australia | ||
| 04:10 | The market shrugged at Mesoblast's latest FDA win. Is it just another Droneshield? | 20 | The Market Herald Australia | ||
| 02:42 | BeiGene celebrates profit milestone on soaring drug sales | 1 | Bamboo Works | ||
| 02:26 | Why Exelixis, Inc. (EXEL) Skyrocketed On Wednesday | 5 | Insider Monkey | ||
| 01:31 | Is Axsome Therapeutics Stock Worth the Risk? A Comprehensive Analysis | 3 | The Motley Fool | ||
| 01:29 | Inhibrx, Inc. Q1 Loss Decreases, Beats Estimates | 1 | RTTNews | ||
| 01:01 | MESOBLAST LIMITED: FDA Provides Ryoncil 7 Years Orphan-Drug Exclusive Approval | - | ASX | ||
| 00:54 | Codexis reiterates $64M-$68M 2025 revenue guidance as ecosynthesis platform gains traction with CDMOs | 3 | Seeking Alpha | ||
| 00:06 | Where BioNTech Stands With Analysts | 13 | Benzinga.com | ||
| Mi | Omeros Q1 2025 Earnings Preview | 2 | Seeking Alpha | ||
| Mi | Tevogen Bio Holdings Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| Mi | AbCellera beginnt Phase-1-Studie für Wechseljahresbehandlung | 1 | Investing.com Deutsch | ||
| Mi | Arbutus Biopharma Corp - 10-Q, Quarterly Report | 6 | SEC Filings | ||
| Mi | AbCellera to begin Phase 1 trial for menopause treatment | 1 | Investing.com | ||
| Mi | SpringWorks Therapeutics, Inc. - 8-K, Current Report | 2 | SEC Filings |
Seite:
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .